Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 111357701000001115 | Tildrakizumab (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 111357801000001112 | Tildrakizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tildrakizumab | Is a | Product containing monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
| Tildrakizumab | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier | ||
| Tildrakizumab | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tildrakizumab 100mg/1ml solution for injection pre-filled syringes | Is a | False | Tildrakizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR